Patient-centric drug development is a concept that has proven to be divisive: Some see it as nothing but a buzzword, while others have embraced the concept completely. Either way, it has garnered much ...

Beyond chronic diseases, CNS drug delivery is also a critical factor in biodefense and national security. As traditional drug-delivery approaches continue to face limitations, alternative methods ...

The controlled release drug delivery market is poised for growth driven by increased R&D, technological advances, and demand for convenient, effective chronic disease treatments. Key opportunities ...

In a new study published in the Journal of Controlled Release, researchers from Tokyo University of Science attempted to minimize and optimize DNA nanostructures for making hydrogels. A Takumi-shaped ...

Key FDA findings: Polymer-to-drug ratios in dissolvable microneedles altered drug release speeds while maintaining penetration ability. Mechanical strength boost: Higher polymer content increased ...

They serve as sustained-release drug delivery systems as they can encapsulate various bioactive substances, including drugs, antigens, and even cells. Hydrogels are better drug delivery alternatives ...

A new nanoparticle platform combines drug delivery with photothermal therapy to overcome multidrug resistance. The approach ...

TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an oncology company integrating novel delivery technology with standard of care therapies, and its investigational immunotherapeutic to ...

DNA hydrogels are biocompatible drug delivery systems for targeted therapeutic interventions. Conventional DNA hydrogels, formed with many DNA nanostructure units, lead to increased preparation costs ...